Recombinant human FGF-21 could reduce the concentrations of total cholesterol, low-density lipoprotein, and high-density lipoprotein, inhibit neuroinflammation, and correct cognitive decline in cognitive impairment caused by hyperlipidaemia (Wang Q. et al., 2018). Here, FGF21 is linked to Cognitive impairment.